Novogene Europe has expanded its single-cell sequencing capabilities in Cambridge, enhancing access to advanced multiomics support in the UK. This development aims to bolster research and clinical applications in genomics.
New service strengthens UK access to advanced multiomics support
Original title: “Novogene Europe expands single‑cell sequencing capability in Cambridge”